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Summary and general discussion 
Main findings 
Beta-carotene (BC) was previously shown to increase lung cancer risk in smokers and 
asbestos exposed subjects. Both types of exposure are typically associated with an in-
flammatory reaction in the lung, and a prolonged inflammation has indeed been shown 
to play an important role in the initiation and promotion of lung cancer. A chronic in-
flammation in the lungs is characterized by an influx of neutrophils and involves the 
generation of cell damaging free radicals. Since it has been reported that BC can act as 
an antioxidant as well as a pro-oxidant [1,2], we aimed in the first part of this thesis to 
gain mechanistic knowledge on the circumstances in which BC acts as an antioxidant 
or pro-oxidant and how BC as such affects radical induced genotoxicity. 
We demonstrate in Chapter 2 that the origin of the radical species to be scavenged af-
fects pro- or antioxidant properties of BC; we observed a protective role for BC against 
carbon centered radicals, but an enhancing effect of BC in hydroxyl radical induced 
damage. Indeed, BC supplemented ferrets had lower amounts of M1dG, a DNA lesion 
resulting from the lipid peroxidation product MDA with carbon centered radical inter-
mediates. However, the oxidative DNA lesion 8-oxo-dG, which directly results from DNA 
oxidation, was not changed in ferrets after BC supplementation, probably because BC 
supplementation also increased base excision repair (BER). 
We subsequently focused on the effect of BC in neutrophil induced DNA damage. 
Smoke and asbestos both induce a chronic inflammation in the lungs [3-6] which is 
characterized by a neutrophilic influx [7]. Activated neutrophils generate high amounts 
of reactive oxygen species (ROS) which can cause oxidative DNA damage. Moreover, ac-
tivated neurophils decrease cellular DNA repair capacity [8]. We demonstrated in Chap-
ter 3 that the BC metabolites; retinoic acid and retinal specifically increased neutrophil 
induced oxidative DNA lesions by decreasing MPO activity, an enzyme active in the con-
version of neutrophil generated hydrogenperoxide. Moreover, BC enhanced the forma-
tion of hydroxyl radicals from hydrogenperoxide. This ultimately resulted in an in-
creased number of oxidative DNA lesions in neutrophil exposed lung epithelial cells 
when exposed to retinoic acid or retinal as measured with the FPG modified comet as-
say. This suggests that adverse effects of BC may be encountered under conditions of 
chronic inflammation.  
BC or its metabolites might thus alter genotoxic effects of smoke or asbestos. Besides 
this effect, BC may also change general gene expression thereby altering the vulnerabil-
ity of lung tissue for smoke or asbestos induced carcinogenesis. Gene expression 
changes induced by high BC intake are difficult to assess; for obvious ethical reasons, 
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humans cannot be supplemented with high amounts of BC, neither is lung tissue easily 
accessible. Moreover, the frequently used in vivo models such as mice and rats highly 
differ in their BC metabolism compared to humans, since they almost completely con-
vert BC into its metabolites, while humans only partly metabolize BC. Consequently, 
BC supplementation results in the accumulation of BC metabolites in rodents, while BC 
supplementation to humans results in accumulation of BC itself [9]. Other animal mod-
els that more resemble BC metabolism have been proposed for BC research. Examples 
are ferrets, gerbils and preruminant calves. However, these models have major disad-
vantages. When using ferrets or gerbils, there is not much knowledge on molecular me-
chanisms and a lack of commercially available molecular tools, which results in pio-
neering research focused on tool development, rather than resolving mechanistic ques-
tions regarding the molecular effects of BC. There is more knowledge with regard to the 
use of calves, however, in that case research is expensive and the calves need special 
housing. We therefore used a “humanized” mouse model in the second part of this the-
sis. In this mouse model there is no functional beta-carotene 15,15’-monooxygenase 1 
(Bcmo1) due to the knock-out of this gene [10]. Consequently, these mice lack the abil-
ity to cleave BC and are like man able to accumulate intact BC. In the second part of 
this thesis we focused on gene expression changes induced by BC in this mouse model, 
to obtain more insights in functional effects of BC to contribute to the lack of knowledge 
of BC action in the lung. In Chapter 4 we explain and discuss the in-house knowledge 
with regard to functional genomics in nutritional studies.  
For the assessment of gene expression effects induced by dietary BC in vivo, we per-
formed a mouse experiment in which female and male, wild type (Bcmo1+/+) and Bcmo1 
knockout mice (Bcmo1-/-) were given a diet containing 1500 IU vitamin A with vehicle 
beadlets (Co) or a diet supplemented with beadlets containing BC to generate 150 
mg/kg diet BC (BC).  
In Chapter 5 we focused on the effect of high BC consumption on gene expression 
changes in lung tissue of female Bcmo1-/- mice. We observed a significant decrease in 
the expression of genes involved in the inflammatory response. After comparison of the 
gene expression with Bcmo1+/+ mice, this decreased inflammatory response appeared to 
be an induced inflammatory response in the lungs of control diet fed female Bcmo1-/- 
mice, which was partly abolished by dietary BC. Histology of the lungs confirmed the 
gene expression results, showing inflammatory infiltrations in lung tissue, only in fe-
male control diet fed mice. These observations were explained by a higher dietary vita-
min A demand in female Bcmo1-/- mice due to an altered expression of downstream BC 
metabolizing enzymes, resulting in a gene expression more focused towards vitamin A 
storage rather than towards retinoic acid production, which is the actual bioactive me-
tabolite. Indeed, a deficiency in retinoic acid is known to result in an inflammations. 
In Chapter 6 we focused on gene expression changes induced in lung tissue of male 
Bcmo1-/- mice after BC supplementation. The higher inflammatory response in lungs of 
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control diet fed Bcmo1-/- mice appeared specific for female mice and was not observed in 
male mice. In male Bcmo1-/- mice however, frizzled homolog 6 (Fzd6) and collagen triple 
helix repeat containing 1 (Cthrc1) were significantly 2.60 and 2.99 fold down regulated 
after BC supplementation. Moreover, many olfactory receptors and protocadherins were 
up regulated. We hypothesized that these gene expression responses were related and 
may be involved in the detection of changes in air composition in the lung, such as hy-
poxia. Since pulmonary endocrine cells (PNECs) are important in the detection of hy-
poxia, particularly this cell type might be affected by BC supplementation. Although 
PNECs account for only 1 in 2500 lung cells [11], 20% of all lung cancer types originate 
from these cells [12], and smoking particularly increases PNEC originated lung cancer 
risk. These findings warrant further research on the role of Fzd6 and Cthrc1 in PNECs. 
The CARET study reported that BC supplementation in both male and female smoking 
and asbestos exposed volunteers resulted in an increased lung cancer risk. Therefore, 
we investigated pathways that were changed in lung tissue of male and female Bcmo1-/- 
mice after BC supplementation in Chapter 7. Interestingly, the genes that were altered 
in their expression by BC supplementation in male and female Bcmo1-/- mice, had an 
opposite direction of the gene expression changes. This suggested a role for BC in the 
regulation of sex-hormones. These changes in lung gene expression were accompanied 
by a significant regulation of many enzymes involved in steroidogenesis and steroid 
conversion. Moreover, testosterone levels were highly variable in BC supplemented 
Bcmo1-/- mice, but not (as expected) in Bcmo1+/+ mice. We therefore hypothesize that BC 
supplementation is able to alter systemic hormone production.  
It is of importance for the risk-benefit assessment of BC, to know whether BC effects 
are specific for lung. Therefore, we compared the BC induced gene expression effects in 
lung tissue with those induced in white adipose tissue, an important BC storage organ 
[13] and liver, important in both BC metabolism and storage [14]. 
In Chapter 8 we illustrate that only a few genes (~1% of the genes regulated by BC sup-
plementation in lung), were also regulated in liver tissue and inguinal white adipose 
tissue (iWAT), and effects of BC on the expression of single genes is highly tissue spe-
cific. Moreover, the magnitude of changes induced by BC supplementation was much 
less than the differences induced by the knockout of Bcmo1 or differences in gender 
(females compared with males).  
Although we found in Chapter 8 that only 1% of the genes regulated by BC in the lung 
were also regulated in liver and iWAT, we found that the pathways that were changed 
by BC in female Bcmo1-/- mice as describe in Chapter 5, or in male Bcmo1-/- mice as 
described in Chapter 6 or the opposite change in gene expression in male and female 
Bcmo1-/- mice as described in Chapter 7, were not specific for lung tissue on pathway 
level which we describe in Chapter 9.  
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Altogether, we find that BC can change inflammation induced genotoxicity and gene 
expression in lung tissue, thereby altering processes that can be involved in lung car-
cinogenesis (Fig. 1). 
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Figure 1: Summary of main findings of BC action as described in this thesis with in bold the corre-
sponding chapters 
Pro-oxidant  OH• ↑ 
Antioxidant  C• ↓ 
(Chapter 2/3) 
Non inflammatory M1dG ↓ (Chapter 2) 
Non inflammatory 8-oxo-dG = (Chapter 2) 
Neutrophil induced 8-oxo-dG ↑ (Chapter 3) 
Inflammation: 
Regulated by BC in ♀  
↑ control diet Bcmo1-/-  
↓ by BC in Bcmo1-/- (Chapter 5) 
Base excision repair capacity 
(Chapter 2) 
division 
PNEC cell division ↑ in ♂ 
Bcmo1-/- (hypothesis)  
(Chapter 6) 
Mechanisms of genotoxicity Protection against mutations 
Incorporation of mutations 
BC influences sex-hormones in Bcmo1-/- mice (Chapter 7) 
 
Effects of BC lung specific? 
 
Effect of BC << effect gender or Bcmo1 genotype (Chapter 8) 
high interaction with tissue, gender and genotype (Chapter 8)  
Number of genes ~ 1% overlap with iWAT and liver (Chapter 8) 
Effects on pathway level are not lung specific (Chapter 9) 
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Discussion of main findings 
In vitro study 
In our study, we used novel approaches to identify modes of action of BC that possibly 
contribute to an explanation for the previously found detrimental effects in the ATBC 
and CARET study. In the first part of this thesis we evaluated the role of BC in radical 
induced genotoxicity in cell lines. We therefore searched, within the limitations of the 
physiology of a cell line, good candidate cells for further in vitro experiments.  
Human lung cancers are categorized into distinct classes, with adenocarcinoma cur-
rently being the most common type of lung cancer (also in non-smokers). It is generally 
believed that the tumor cells from this cancer originate from type II cells, which cover 
~5% of the alveolar surface [15]. It has indeed been shown that most of the tumor cells 
express surfactant protein-C, which is characteristic for type II cells and do not express 
the Clara cell specific protein (CCSP) [16]. The presence of lamellar bodies in lung car-
cinoma cells has also been demonstrated, in combination with electron dense granules 
and mitochondria, although this is a common characteristic for Clara cells [17]. 
Therefore, In order to find a suitable cell line for our in vitro studies, we used electron 
microscopy to characterize several lung cell lines to choose a cell type containing lamel-
lar bodies and mitochondria as can be seen in Fig. 2. 
A) B) C) D) E) F) G) 
       
 
Figure 2. Electron photomicrographs of lung cell lines. A: A549 human type II cell line B: MLE-12 
mouse type II epithelial cell line. C: L2 rat type II cell line D: BEAS-2B human bronchial epithelial cell 
line E: HBE-4 human bronchial epithelial cell line F: HBE-135, human bronchial epithelial cell line G: 
NL20, human bronchial epithelial cell line. Arrows indicate lamellar bodies, arrow heads indicate mi-
tochondria, N: nucleus.  
We also tried to identify the presence of CCSP and surfactant protein A and C, known 
markers of type II cells [18], to confirm the cell line histology. Unfortunately, we were 
not able to quantify these proteins due to low quality antibodies.  
 N 
N 
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On basis of these results, we specifically selected Beas-2B cells and A549 cells since 
they are human derived, and thereby having a BC metabolism probably more similar to 
that of humans. Moreover, these cells contain lamellar bodies, specific for carcinoma 
derived from type II cells. Of course one might question the physiological relevance of 
A549 cell, since they are of cancer origin. Since we were specifically interested in effects 
of BC and BC metabolites on genotoxicity, we think that the antioxidant properties of 
surfactant as stored in lamellar bodies, present in BEAS-2B and A549 cells, is more 
important than the characteristics of the immortalization. 
From our gene expression studies, we suggest that pulmonary neuroendocrine cells 
(PNECs) would be an interesting additional cell type to study mechanisms of BC action 
in lung tissue [19,20]. However, at this moment no cell line is characterized as PNEC 
cell using the PNEC markers CGRP, Chromogranin A, peptide YY [18]. We expect that in 
future experiments, a PNEC cell line is the preferred choice to study the effect of BC on 
smoke or asbestos induced carcinogenesis. 
Besides the use of immortal cell lines, we also used primary human neutrophils derived 
from several healthy volunteers to investigate the effect of BC metabolites on MPO activ-
ity and on the generation of oxidative DNA lesions. 
In vivo ferret studies 
To assess the effect of BC supplementation on changes in human lung tissue, ferrets 
are considered as a suitable model [21]. BC metabolism in ferrets and humans is highly 
similar while BC metabolism in rodents, such as rats or mice, differs greatly from BC 
metabolism in humans [9]. Therefore, we also attempted to assess the effect of BC on 
gene expression changes in lung tissue of ferrets. For that experiment, 6 ferrets per 
group were fed a) a control diet, b) supplemented with 0.8 mg BC/kg body weight/day, 
c) supplemented with 3.2 mg BC/kg body weight/day, d) fed the control diet and sup-
plemented with 8 mg B[a]P/kg three times a week or e) supplemented with 0.8 mg 
BC/kg body weight/day and supplemented with 8 mg B[a]P/kg three times a week as 
described in Chapter 2. Since no ferret arrays were (and are) commercially available, 
the homology of ferret RNA to hybridize against in-house made human and mouse 
cDNA arrays was tested and resulted in 32% spots three times above background in the 
human array, and 23% spots three times above background in the mouse array, and 
thus we concluded that ferret lung RNA had the best hybridization quality with human 
microarrays compared to mouse microarrays. Thereafter, we embarked on a precarious 
enterprise and hybridized ferret lung RNA to a human cDNA array. Of course, it was of 
upmost importance to confirm effects found on the human array by ferret specific Q-
PCR. Unfortunately, not many ferret specific sequences are present in publically avail-
able databases. Therefore, we sequenced parts of specific genes of ferret cDNAs to be 
able to design ferret specific primers for ferret specific Q-PCR. 
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After sequencing these ferret specific cDNA fragments, the species canis lupus familiaris 
(i.e., the dog) appeared to have most sequence homology with ferrets, followed by hu-
man as can be seen in Table 1. This is in agreement with the percentage of genes above 
background on the human and mouse microarrays. The effects of BC observed in the 
ferret experiment using microarrays designated for human could not be confirmed by 
Q-PCR, underlining the difficulties in molecular research using ferrets. 
Table 1: percentage homology of ferret RNA sequence with human, mouse, rat or dog RNA sequence. 
Gene Abbreviation Homo 
Sapiens 
Mus Mus-
culus 
Rattus 
Nervoricus 
Canis Lupus 
Familiaris 
Tropomyosin 1; TPM1 TPM1α 95% 92% 90% 96% 
Calnexin CANX 85% Not found Not found Not found 
H3 Histone Family 3A H3F3 94% 86% 89% 97% 
Histone 1, 4F H4F 90% 95% 95% 95% 
Histone deacetylase 1 HDAC1 94% 91% 92% 97% 
Nuclear receptor corepressor 1 NCOR1 97% 94% 94% 98% 
Retinoic Acid Receptor beta RARβ 94% 88% 89% 96% 
Thymosin beta 10 TMSB10 89% Not found 88% 94% 
Tight junction protein TJP 97% 95% 96% 98% 
Acetyl-CoA Acyltransferase 2 ACAA2 87% 85% 85% Not found 
Actin beta ACTB 94% 90% 90% 94% 
Creb binding protein CREBBP 88% 87% 88% 94% 
H2A histone family H2A 100% 98% 99% 100% 
Histone acyltransferase 1 HAT 96% 94% 96% 99% 
E1A binding protein p300 EP300 95% 92% 92% 79% 
P300/CBP-associated factor PCAF 91% 86% Not found 97% 
Prothymosin alpha PTMA 96% 92% 93% 99% 
Histone deacetylase 2 HDAC2 92% Not found 85% 94% 
Histone deacetylase 3 HDAC3 81% Not found 77% 87% 
Ribosomal protein L17 RPL17 91% 88% 88% 95% 
Species with the most homology with ferret sequence in bold and grey 
Ferrets are also a preferred animal model in influenza research [22]. Recently, gene ex-
pression changes induced by avian influenza H5N1 in lung tissue of ferrets were ana-
lyzed using Canine arrays [23]. Canine arrays were chosen since 30 publically available 
ferret sequences had the highest (89%) homology with canine sequences. We found 
much higher homologies, which is probably caused by choosing highly conserved re-
gions between human, mice, rats and dogs to increase the chance of a successful PCR. 
Overall, the results on ferret mRNA analysis on human microarrays could not be con-
firmed by Q-PCR, and therefore this approach was aborted. Since then the microarray 
quality is highly improved and continuously developed. Therefore microarray studies in 
ferrets may be possible in the near future. 
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In vivo Bcmo1-/- mouse model 
We used Bcmo1-/- mice to evaluate effects induced by BC in the second part of this the-
sis.  
 
Figure 3: Experimental setup of the mouse experiment used in Chapter 5-9 of this thesis. Six animals 
per arm of the experiment. 
The setup of the experiment is shown in Fig. 3 and appeared highly effective to dissect 
effects induced by BC supplementation in the Bcmo1-/- mice from effects induced in 
Bcmo1+/+, and effects induced in female mice from effects induced in male mice. The 
effect of BC decreasing the inflammatory response in female Bcmo1-/- mice as described 
in Chapter 5, would be interpreted as a decrease in inflammation when no Bcmo1+/+ 
mice were taken along. We now assume that female Bcmo1-/- mice are more vulnerable 
for vitamin A deficiency and that BC is able abolish this effect. Moreover, the effects of 
BC on transcription were different in male and female Bcmo1-/- mice as described in 
Chapter 5 and Chapter 6 and resulted in opposite direction of gene-regulation of com-
monly regulated genes in Bcmo1-/- mice as described in Chapter 7.  
We discussed in Chapter 4 that a good setup of an in vivo mouse experiment is an im-
portant prerequisite to obtain enough power to statistically significantly assign the 
small effects as are often observed by nutritional interventions. In contrast to the rec-
ommended n=12, in our experiment we used only 6 animals per group. This was done 
Bcmo1+/+ 
Bcmo1-/- 
Bcmo1+/+ 
Bcmo1-/- 
Female 
Male 
14 weeks 
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because this was the maximum capacity when taking breeding into account. Neverthe-
less, the differences that we have described are statistically significant, and thus 
enough power must have been obtained. The pathways that were significantly regulated 
in lung tissue after BC supplementation in Bcmo1-/- mice were also differentially regu-
lated by BC in iWAT and liver as has been described in Chapter 9, which can be taken 
as confirmation of the power of the experiment. 
Interpretation of main findings 
The effect of BC on inflammation 
We showed in Chapter 2 that BC supplementation specifically decreased carbon cen-
tered radical formation, resulting in a decrease in the formation of M1dG in ferrets. 
However, hydroxyl radical formation was increased, especially in our in vitro experi-
ments. Because BC supplementation also increased DNA repair capacity (BER), BC 
supplementation did not result in an increase in the oxidative DNA lesion 8-oxo-dG in 
vivo. Thus, sufficient BC normally has beneficial effects on genotoxicity. Since an in-
flammatory response in the lungs is mainly characterized by an increase in neutrophils 
[7], we investigated the effect of BC or its metabolites on neutrophil induced oxidative 
DNA lesions. We found that retinoic acid and retinol were able to increase neutrophil 
induced oxidative DNA lesions as described in Chapter 3. This results in a lower bene-
ficial effect of BC in neutrophil exposed (smokers or asbestos exposed subjects) humans 
as compared to non-exposed subjects, as is displayed in Fig. 4.  
 
 
Figure 4: Hypothetical benefit-risk of BC on neutrophil induced genotoxicity in subjects that have a 
low neutrophilic influx in the lungs (solid line) and a high neutrophilic influx in the lungs (dashed 
lines). BC has beneficial effects towards radical centered radicals which results in a decrease in levels 
of the pro-mutagenic M1dG. However, BC increases neutrophil induced levels of 8-oxo-dG. The pres-
ence of neutrophils is increased in smokers and asbestos exposed subjects and therefore results in a 
smaller window of benefit.  
risk 
benefit 
window of benefit 
intake 
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Although we show that these BC metabolites have the ability to increase neutrophil in-
duced oxidative DNA lesions, it must be emphasized that these results were obtained by 
using cell lines. Cell lines often display altered gene expression resulting in, for exam-
ple, a non-physiological poor antioxidant enzyme or repair enzyme signature [24]. Nev-
ertheless, these data show that BC metabolites have the potential to enhance neutro-
phil induced oxidative stress. 
In Chapter 5 we also described that inactivation of Bcmo1 resulted in inflammatory 
infiltrations in lungs of female Bcmo1-/- mice, which was abolished by dietary BC. We 
explained this effect by an altered downstream BC metabolism, resulting in a higher BC 
demand. BC supplementation resulted in a decrease of the inflammatory response, and 
results in a changed benefit-risk figure dependent on BCMO1 activity as is displayed in 
Fig. 5. A genetic polymorphism in BCMO1 has been described in humans, which is as-
sociated with a lower BCMO1 activity.  The vitamin A content in the control diet ap-
peared, in contrast to females, physiologically sufficient for male Bcmo1-/- mice, but we 
don’t know the mechanism at this moment.  
 
 
Figure 5: Hypothetical benefit-risk of BC in the female “low response” phenotype (solid line) and “low 
converter“ phenotype. Females that have polymorphisms in the BCMO1 enzyme (associated with lower 
activity of BCMO1) might have a higher vitamin A demand, as was observed in female Bcmo1-/- mice 
(Chapter 5). Vitamin A deficiency results in adverse effects such as an increase in inflammation. Be-
cause of the higher Vitamin A demand, the window of benefit of the low converter phenotype shifts to 
the right in the figure.  
Thus, significantly decreased levels of BC or BC metabolites can increase inflammation. 
Interestingly, smokers have both an increased inflammatory response, and decreased 
risk 
benefit 
Window of benefit 
intake 
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vitamin A levels. An inverse correlation between the degree of inflammation and BC has 
been observed in several studies. For example there is an inverse correlation between 
white blood cell count and BC concentration in non-smokers [25] and smokers [26,27]. 
But, is the BC concentration modulating the inflammatory response, or does the in-
flammatory response alter BC levels? There is evidence for both theories. Increases in 
inflammation are usually associated with increased oxidative stress. BC is highly sus-
ceptible to oxidative degradation and several studies have shown that BC cleavage rap-
idly occurs after exposure to oxidative reagents such as hypochlorous acid [28,29]. This 
theory however, explains only part of the inverse correlation between BC concentration 
and the degree of inflammation. Studies that measured several carotenoids demonstrate 
that BC concentrations are decreased to a higher extent during inflammation than the 
more oxidative sensitive carotenoids such as lycopene and lutein [25,30]. This suggests 
that lower BC status increases inflammation. In agreement with this hypothesis, stud-
ies have shown that deficiency of the BC metabolite vitamin A is associated with an in-
creased severity of infections and more deaths from infectious diseases; supplementa-
tion with vitamin A reduced these effects [31,32]. Supporting these data, vitamin A defi-
ciency in rats resulted in inflammatory infiltrates in lungs [33]. To investigate the simi-
larities between vitamin A deficiency and smoke induced histological changes in the 
lung, lungs of vitamin A deficient rats [33] were histologically compared to lungs of 
smoke exposed rats [34]. Remarkably, these lungs showed a similar structure, with em-
physematous areas and inflammatory infiltrates [35].  
The molecular mechanism underlying the vitamin A induced effects on the immune re-
sponse are not well understood. As described in the introduction, RAR and RXR are 
transcription factors able to bind the retinoic acid responsive element in promoter re-
gions of RAR-responsive genes. Retinoic acid binding to this receptor can consequently 
result in a gene expression response [36,37]. RARα and RARγ are the predominant 
forms expressed in immunological cells, and RARγ knockout results in a decrease in 
total white blood cell counts [38]. All-trans retinoic acid is, in contrast to its activating 
role for RAR, an effective repressor of ROR, and binding of retinoic acid has been shown 
to decrease immunological responses [39]. Altogether these observations lead to a hy-
pothesis that a deficiency in the bioactive metabolite retinoic acid might lead to an in-
creased inflammation in the lungs. In our study, supplemental BC was beneficial. Me-
chanistic knowledge on inflammatory responses during retinoic acid deficiency is of 
importance and might lead to mechanisms that explain the previously identified detri-
mental effects and might identify other vulnerable groups. 
Retinoic acid resistance? 
Thus negative effects of vitamin A deficiency on inflammation have been reported. Fig. 6 
depicts that vitamin A deficiency results in an increased inflammatory response. This 
raises the question: “Is it possible that a chronic supplementation with BC eventually 
results in a decrease of the bioactive metabolite retinoic acid?” We investigated this pos-
sibility in literature.  
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Figure 6: Vitamin A concentration can modulate the inflammatory response. During deficiency, in-
flammation is increased (solid line). High dose supplementation of the bioactive metabolite retinoic 
acid can increases inflammation in APL patients (dashed line) [40]. 
During illness, all-trans retinoic acid is frequently used as a therapeutic agent in pa-
tients suffering from acute promeyelocytic leukemia (APL). Without any other medica-
tion, around 25% of the patients develop the retinoic acid syndrome. Typical for the 
clinical manifestations of the retinoic acid syndrome are pulmonary effects (Table 2) and 
typical is that a large percentage of patients suffer from inflammatory infiltrates [41,42]. 
Although the exact mechanisms are unknown, these data indicate that an increase in 
retinoic acid might become detrimental under certain conditions. 
Table 2: clinical manifestations of the retinoic acid syndrome [43]. 
Manifestation  % of Patients 
Respiratory distress  84 
Fever  81 
Pulmonary edema  54 
Pulmonary infiltrates  52 
Pleural/pericardial effusion  36 
Hypotension  18 
Bone pain  14 
Headache  14 
Congestive heart failure  11 
Acute renal failure  11 
Vitamin A or bioactive derivative D
eg
re
e 
of
 in
fla
m
m
at
io
n
 
Summary and general discussion 
 
 213  
 
 
Retinoic acid levels are thought to be very well regulated [44]. Since the measurement of 
retinoic acid involves sophisticated equipment, the retinoic acid precursor retinol is 
measured in most studies that investigate effects of carotenoids. In contrast to the as-
sumed stable retinoic acid levels, consumption of BC rich carrot juice resulted in stable 
retinol plasma concentrations, but almost doubled retinoic acid plasma concentrations 
[45]. This study was performed for the duration of only two weeks. What happens with 
retinoic acid levels after prolonged supplementation with beta-carotene is unknown, but 
for example, prolonged all trans retinoic acid treatment causes an increase in RA ca-
tabolism and can lead to retinoic acid resistance [40,46]. This is mainly caused by an 
increased Cytochrome P450 family 26 (CYP26) capacity. These studies indicate that RA 
levels may be altered after BC administration and that prolonged period of elevated RA 
levels induces an increase in RA catabolism. Moreover, we observed in Chapter 5 and 
Chapter 6 a positive correlation between BC concentrations in lung and retinyl ester 
concentrations in the lung. This indicates that there is a controlled balance between 
concentrations of BC and its stored form. When a more chronic BC supplementation is 
attenuated, BC might be stored at similar levels, while RA turnover is increased result-
ing in a physiological deficiency. This hypothesis is more or less strengthened by some 
adverse effects that have been observed in RA therapy. Administration of retinoic acid 
can induce RA hypercatabolism and patients cannot be actively treated with retinoic 
acid after a first therapy even when the dose is doubled [47,48]. Moreover, decreases in 
endogenous retinol stores down to 40% have been observed in patients with exogenous 
retinoid therapy and resulted in adverse effects on vision [49]. Moreover, the retinoic 
acid syndrome is characterized by weight gain (retinoic acid increase results in the op-
posite [41]) in association with pulmonary infiltrations. 
Smokers have lower carotenoid levels, as we have described above and ferrets exposed 
to cigarette smoke have around half the retinoic acid concentration in their lungs com-
pared to control ferrets [50]. Moreover smoke has been shown to induce RA catabolism 
in ferrets [51]. Therefore, smokers are probably already more vulnerable for a deficient 
state and decrease in retinoic acid might quickly result in an increase in the inflamma-
tory response, which is similar to the observation of an increased inflammatory re-
sponse in lungs of control diet fed female Bcmo1-/- mice, which was abolished by dietary 
BC.  
BC metabolism: the important determinant in BC induced effects? 
Many of our described effects are possibly the effect of changes in retinoic acid concen-
tration, induced by BC supplementation. We explained part of these effects by differ-
Chapter 10 
 
214   
 
ences in downstream BC metabolism (Chapter 5 and Chapter 6). This raises the ques-
tion whether smoke or asbestos exposed subjects might have an altered downstream 
BC metabolism compared to healthy volunteers. Although this question was never di-
rectly addressed in human lung tissue, technology evolved and microarray data are 
usually publicly accessible with which this question could be answered (at least in 
part).  
We used GEO Datasets (http://www.ncbi.nlm.nih.gov/gds) to analyze the effect of 
smoking on the gene expression of BC metabolizing enzymes, using 4 studies (Table 3). 
Unfortunately, no data were available from lung tissue of asbestos exposed subjects. 
The most remarkably changed downstream BC metabolizing enzyme is ADH7, the most 
important enzyme in the conversion of retinol into retinal [52].  
Table 3: Enzymes involved in downstream BC metabolism that are significantly changed in smokers 
(based on publicly available microarray data at: http://www.ncbi.nlm.nih.gov/gds).  
target 
tissue 
smokers 
(n) 
control 
(n) 
ADH7 ADH1a3 DHRS3 BCMO1 Aldh2 refer-
ence 
large air-
way epithe-
lium 
26 17 3.74 (1.69e-9) 
1.736 
(0.0006) n.p. n.p. 
-1.09 
(0.270) [53] 
small air-
way epithe-
lium 
10 12 7.21 (1.35E-7) 
1.368 
(0.001) 
1.237 
(0.058) 
-1.16 
(0.049) 
-1.099 
(0.16) [54] 
small air-
way epithe-
lium 
6 5 6.434 (4.06e-5) 
1.732 
(0.0748) 
1.099 
(0.2136) 
1.398 
(0.395) 
-1.177 
(0.299) [55] 
general 
airway 33 22 
2.52 
(1.35e-08) 
1.44 
(0.0085) 
1.498 
(1.03e-8) 
1.286 
(0.234) 
-1.23 
(0.002) [56] 
n.p.: not present in database; p-value between brackets 
We found in Chapter 5 that Adh7 was also significantly up regulated in female Bcmo1-/- 
mice after BC supplementation and non significantly in male Bcmo1-/- mice after BC 
supplementation. These data suggest that BC supplementation to smokers, which have 
already increased ADH7 activity, might lead to an additive or even synergistic effect of 
BC on ADH7 expression. This might have important implications of BC on smoke in-
duced carcinogenesis, since ADH7 has also been shown to have an increased activity in 
many types of cancer such as esophageal cancer [57] and gastric cancer [58]. 
Gender effect 
Interestingly, the observed effects of BC in Bcmo1-/- mice were gender specific. This re-
sulted in an increase in inflammatory gene expression in control diet fed Bcmo1-/- mice 
which was specific for female mice as described in Chapter 5, while the decrease in 
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Fzd6 and Cthrc1 in combination with the increase in olfactory receptors and protocad-
herins after BC supplementation to Bcmo1-/- mice were specific for male mice as de-
scribed in Chapter 6. Moreover, the effects induced by BC supplementation in both 
male and female mice were regulated in opposite direction as described in Chapter 7. 
These differences have also implications for differences in the benefit-risk figure. Fe-
males seem to have a higher vitamin A demand than males, which results in a shift to 
the right for the start of the hypothetical window of benefit in female as can be seen in 
Fig. 7. 
 
Figure 7: Hypothetical benefit-risk figure for male (solid) and female (dashed). Female Bcmo1-/- mice 
seem to have a higher vitamin A demand than male mice. 
We explained the opposing gene expression differences found in lung tissue, by a 
change in hormones or steroid biosynthesis due to an evolutionary conserved overlap in 
the production of BC in plants and the steroid synthesis in mammals [59]. We found a 
significant change in the GO process steroid biosynthesis in male Bcmo1-/- mice after 
supplementation with BC. This process might be the cause of the opposing gene ex-
pression differences in male and female mice or its consequences. In Chapter 9, we 
focused on the effect of BC supplementation in iWAT and liver and we also found an 
opposite direction of gene regulation in iWAT in male and female Bcmo1+/+ mice after 
BC supplementation. Similar to lung tissue, the GO process steroid biosynthesis was 
significantly regulated in one of the two genders after BC supplementation (Table 4). 
There were a few genes commonly regulated in the steroid biosynthesis process between 
male Bcmo1-/- mice and female Bcmo1+/+ mice after BC supplementation, including 
MvK, Hmgcs1, Fdps and Cyp51 There are also two genes regulated in both iWAT of fe-
male Bcmo1+/+ mice and lung tissue of male Bcmo1-/- mice that play an important role 
in the conversion of steroids and thereby regulates the sex hormone bioactivity in the 
target tissue. Hsd17b12 converts estrone into the bioactive 17β-estradiol [60] and 
Hsd17b7 has been shown to have a dual role: activation of estrogens by converting es-
trone into 17β-estradiol, while Hsd17b7 inactivates dihydrotestosterone (DHT) by trans-
risk 
benefit 
window of benefit 
intake 
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forming this into 5alpha -androstane-3beta,17beta-diol (3beta-diol) [61]. Changes in 
hormone production or activity normally results in physiological effects in adiposity. 
Sex steroids play a key role in the distribution of adipose tissue [62,63]. This is for ex-
ample exemplified by a reduced degree of central obesity by hormone replacement ther-
apy in postmenopausal woman and testosterone replacement therapy in older man [63]. 
Similarly, we found that adiposity was significantly decreased in female Bcmo1+/+ mice, 
while not in male Bcmo1+/+ mice as can be seen in Fig. 8. 
Table 4: Genes present (until p=0.05) in the significantly regulated GO process steroid biosynthesis in 
iWAT of female Bcmo1+/+ mice after BC supplementation. 
Probe Score Symbol Name  
A_52_P67637 4.56E-04 Sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) ho-
molog (S. cerevisae) 
A_51_P153170 5.25E-04 Cyb5r3 cytochrome b5 reductase 3 
A_51_P418056 9.51E-04 Sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) ho-
molog (S. cerevisae) 
A_52_P118161 0.001033 Lss lanosterol synthase 
A_52_P35064 0.001037 Tm7sf2 transmembrane 7 superfamily member 2 
A_51_P482711 0.001257 Dhcr24 24-dehydrocholesterol reductase 
A_51_P209372 0.002543 Sc4mol sterol-C4-methyl oxidase-like 
A_51_P329711 0.004309 Idi1 isopentenyl-diphosphate delta isomerase 
A_51_P492408 0.005526 Pmvk phosphomevalonate kinase 
A_51_P290986 0.006027 Dhcr7 7-dehydrocholesterol reductase 
A_51_P492410 0.006296 Pmvk phosphomevalonate kinase 
A_51_P146941 0.007138 Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 
A_51_P158922 0.009218 Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunit 
A_52_P164161 0.009666 Cyp51 cytochrome P450, family 51 
A_51_P379798 0.0128 Fdps farnesyl diphosphate synthetase 
A_52_P58006 0.01367 Acbd3 acyl-Coenzyme A binding domain containing 3 
A_52_P243599 0.01445 Hsd17b12 hydroxysteroid (17-beta) dehydrogenase 12 
A_52_P636752 0.01622 Cyp51 cytochrome P450, family 51 
A_51_P169527 0.02114 Mvk mevalonate kinase 
A_51_P355943 0.02238 Mvd mevalonate (diphospho) decarboxylase 
A_52_P1013551 0.02461 Nsdhl NAD(P) dependent steroid dehydrogenase-like 
A_52_P566605 0.02528 Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 
A_51_P485791 0.02842 Cyp51 cytochrome P450, family 51 
A_51_P326942 0.03472 Nsdhl NAD(P) dependent steroid dehydrogenase-like 
A_52_P388072 0.0392 Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 
A_52_P297803 0.04138 Nsdhl NAD(P) dependent steroid dehydrogenase-like 
A_51_P296487 0.04157 Lss lanosterol synthase 
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Thus the adiposity index ‘perfectly’ corresponds to the changes in the biosynthesis 
process. There is however no effect seen in adiposity in males and certainly more re-
search is needed to identify the specific effects and mechanisms of BC induced effects 
on hormone synthesis or bioactivity. 
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Figure 8: Adiposity index (gram adipose tissue per kg body weight) in female and male Bcmo1+/+ mice 
in control diet fed mice (white bars) and BC supplemented mice (black bars). ** p<0.01 with Students’ 
t-test. Error bars represent SEM. 
Interaction of BC with xenobiotics? 
The effect of BC resulting in an increased lung cancer risk as described in the CARET 
and ATBC trials was observed in subjects that were exposed to either cigarette smoke or 
asbestos. In this thesis we tried to obtain more insight in molecular mechanisms 
changed by BC in lung tissue. There are some indications that xenobiotic exposure 
such as in smoking, alters lung biology, thereby additionally altering effects of BC. In 
Chapter 2, ferrets were exposed to B[a]P for 10 weeks. B[a]P is one of the best studied 
chemical pro-carcinogens and is present in cigarette smoke. B[a]P is metabolic activated 
into BPDE, a chemical carcinogen able to form adducts with the DNA [64]. Fourteen 
weeks after the B[a]P intervention had stopped, BPDE-DNA adducts were still detectable 
in the ferrets’ lung. More remarkably, B[a]P exposed ferrets had significantly lower 8-
oxo-dG levels and had a significantly increased BER capacity. Previously a single dose 
of B[a]P was associated with an increased urinary excretion of 8-oxo-dG and a decrease 
in 8-oxo-dG in the DNA [65]. Although an exact mechanism was not tested, we found a 
significant increase in BER capacity after B[a]P exposure. Moreover, we found a signifi-
cant negative correlation between 8-oxo-G and BPDE-DNA adducts as can be seen in 
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Fig. 9, indicating that the presence of these BPDE adducts was possibly sufficient to 
increase BER capacity.  
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Figure 9: Correlation between BPDE-DNA adducts and 8-oxo-dG in ferrets fourteen weeks after the 
last B[a]P exposure in ferrets fed the control diet (circles) or fed 0.8 mg/kg BC (squares) (R=0.74, 
p<0.01). 
Although only smokers and not asbestos exposed subjects are exposed to high concen-
trations of B[a]P, this example illustrates that xenobiotic exposures, are of importance 
in the ultimate result of the effect of BC on inflammation induced genotoxicity.  
One xenobiotic that is present in both cigarette smoke as well as asbestos is iron. Ciga-
rette smoke contains high amounts of iron (440-1150 μg/g tobacco) [66] and also as-
bestos fibers are associated with high concentrations of iron. The amphibole fibers have 
a high iron content (27-33%), while chrysotile asbestos has relatively small iron con-
tents (6%) [67], and epidemiological studies show that asbestos fibres that contain high 
amounts of iron are more carcinogenic than the low or non-iron containing counter-
parts [68]. Moreover, iron, mainly in the Fe3+ form, can bind and accumulates on asbes-
tos fibres [69]. The main mechanism described for the possible detrimental effects of 
iron is the Fenton reaction: 
Fe2+ + H2O2  Fe3+ + •OH + -OH 
We proposed in Chapter 3 that BC and its metabolites are able to reduce Fe3+ into Fe2+, 
thereby increasing radical formation in the Fenton reaction. Besides this effect of BC on 
iron mediated radical formation, we actually found in Chapter 3 that BC was also able 
to reduce the activity of the iron containing enzyme MPO.  
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Moreover, we found that BC was able to decrease the activity of the iron containing en-
zyme horse radish peroxidase 2-fold (unpublished data). Altogether, these data impli-
cate that BC might alter iron biology.  
Besides the investigated effect of BC and its metabolites on the generation of oxidative 
stress, BC or its metabolites might also have a role in the uptake of iron. Fe3+ has very 
low solubility at neutral pH and accumulates onto the particle surfaces. It is known 
that reducing agents present in the lung, such as ascorbate, are able to reduce Fe3+ into 
Fe2+, thereby displacing the iron from the complexed surface [70]. Moreover, the uptake 
of iron under physiological conditions is probably also dependent on its valence. Fe3+ 
has very low solubility at neutral pH and reduction of Fe3+ into Fe2+ has been consid-
ered as essential in iron absorption [71]. There are only a few studies describing the 
effect of BC or BC metabolites on iron uptake, and they mainly focus on dietary iron 
absorption and distribution. It has been shown that vitamin A and BC were able to im-
prove dietary nonheme iron absorption in colorectal cells of human subjects [72,73] and 
changes from vitamin A deficiency towards sufficiency also resulted in organ specific 
alterations in iron content [74,75]. Moreover, RBP4, the main transporter of retinol, has 
been associated with increased concentration of ferritin, the main protein that com-
plexes with iron, which indicates a relation between BC metabolite retinol and iron biol-
ogy [76,77]. These data indicate that BC or its metabolites might be involved in the 
physiological effects of iron in lung tissue.  
How to continue to assess the risk of BC? 
The aim of this thesis was to assess molecular mechanisms altered by BC action in the 
lung to contribute to an explanation for the previously observed adverse effects of BC on 
lung cancer risk. Novel observations have been made that a) contribute to explanations 
for the negative effects observed in the CARET and ATBC studies and at the same time 
agree with the many beneficial effects of BC and b) suggest novel roles of BC/RA me-
tabolism in cell biology and c) show that large gaps remain in our knowledge of BC/RA 
biology. 
With plenty new data, we would like to discuss questions resulting from this thesis that 
have to be addressed on the road towards benefit-risk assessment that will help to de-
fine a recommended daily intake and a upper limit of BC. When questions are ad-
dressed regarding the effect of BC on lung tissue in humans, we are faced with (ethical) 
limitations since detrimental effects have been observed and lung tissue is difficult and 
too invasive to obtain. In vitro models are perfects tools to study molecular mechanisms 
in detail. We successfully used this approach in Chapter 2 and Chapter 3. In vitro 
studies however often fail when questions regarding the physiological response of a spe-
cific tissue to stimuli or compounds are tested in the context of the whole organism, 
taking absorption, distribution, metabolism and the effect on an organ due to interac-
tions with other organs into account. We found that the response of lung tissue to oral 
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BC administration was different for female and male, as has been discussed in Chapter 
5 and Chapter 6, and that there is possibly even an interaction with other organs such 
as the steroid producing organs as has been described in Chapter 7 or with the im-
mune system as has been described in Chapter 5. 
As we discussed, there are still many gaps in the knowledge on the action of BC. Still 
many scientifically and socially relevant questions need to be addressed. We will dis-
cuss some of these questions below in combination with an suggested approach to-
wards their answer. 
Are the effects found in Bcmo1-/- mice induced by BC or retinoic acid? 
In our study we used Bcmo1-/- mice, which were described previously [78]. Although 
Bcmo1 is the main BC metabolizing enzyme [79], we observed that in our studies BC 
was able to abolish a vitamin A deficient state. We assume that Bco2, implicated in BC 
metabolism [80] with a low affinity for BC, was involved in this conversion of BC to cor-
rect for retinoic acid needs (Chapter 5).  
An appropriate animal model to investigate the effects of intact BC would therefore be a 
mouse model with a knockout for Bcmo1 and Bco2. When using this mouse model, WT 
controls have to be taken into account to correct for effects induced by possible altera-
tions in downstream BC metabolism such as vitamin A deficiency, as we have observed 
for the female Bcmo1-/- mice in Chapter 5. An alternative to a Bcmo1/Bco2 knockout 
mouse model might involve a bypass of the enterocytes. After absorption, most BC is 
cleaved in the enterocytes of mice and rats by Bcmo1 [81]. There are ways to bypass the 
most efficient cleavage sites, for example by injecting BC or by the use of implantable 
pumps, such as Alzet pumps. BC concentrations and accumulation have to be tested 
since these experiments have not been performed before, and other organs such as liver 
are known to metabolize BC in mice as well [9]. 
To investigate the effects induced by RA, wildtype mice are perfectly suitable. These 
mice can be supplemented with retinoic acid although these mice might induce RA hy-
percatabolism. To circumvent this, it might be better to supplement mice with retinoic 
acid metabolism blocking agents, which specifically block CYP26 and thereby prevent-
ing RA catabolism and increase RA concentrations [51].  
When performing BC or retinoic acid research in these animal models, the diet of the F1 
generation as well as the dams should be considered carefully. Most experimental 
(chow) diets contain high concentrations of vitamin A and BC. Dams are able to store 
these high concentrations of vitamin A, and will also deliver vitamin A to their offspring. 
Although generally vitamin A stores are low at birth in humans and rodents, because of 
a limited transplacental vitamin A transfer [82-84], lactating periods are crucial for the 
vitamin A stores in the neonates. As a consequence, the amount of vitamin A in the 
milk, which is dependent on maternal vitamin A stores and the amount of vitamin A 
present in maternal feed [85,86], is an important determining factor in vitamin A stores 
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of the offspring. The hepatic vitamin A stores at the start of the experiment will affect 
general BC and vitamin A physiology and thus can result in variations in the outcome 
of experiments investigating effects of BC or BC metabolites. For example Bcmo1 was 
shown to be not essential in the maintenance of vitamin A stores when BC is the main 
source of vitamin A [87]. However, in another study where dams were depleted of vita-
min A, the enzyme played an important role and changed the conclusion of the role of 
Bcmo1 [10]. Our experiment carefully considered vitamin A concentration in diet fed to 
the dams. High hepatic vitamin A stores reduce dietary BC uptake and therefore the 
dams were fed a diet containing 1500 IU/kg feed which is considered a vitamin A suffi-
cient diet [correspondence with Von Lintig/Wyss] in our study. The increased inflamma-
tion in female control diet fed Bcmo1-/- mice however suggests that these mice were 
mildly vitamin A deficient, as discussed in Chapter 5.  
Are there differences between a short and long BC intervention and can chronic 
BC supplementation result in BC or RA resistance? 
The subjects in the ATBC and CARET study were supplemented with BC for medians of, 
respectively, 6.1 and 4 years with 20 mg or 30 mg of BC, which resulted in an increased 
lung cancer risk in smokers and in asbestos exposed subjects [88-90]. To evaluate 
changes induced by BC supplementation, the effect of a short and chronic intervention 
has to be assessed. This might lead to insight about a possible BC or retinoic acid resis-
tance.  
Is there a method to assay the bioactive potency induced by BC supplementa-
tion? 
The bioactive potency of BC is mainly attributed to changes in RA as discussed in 
Chapter 1. Unfortunately we were not able to measure RA in the samples. At this mo-
ment it is also not completely known whether only RA has the ability to induce gene-
transcription. There might be a few ways to measure the bioactive potency in tissues or 
plasma after BC intervention.  
A first method is the measurement of RA analytically, which unfortunately requires so-
phisticated equipment. This approach may not be sensitive enough and has the disad-
vantage that bioactivity is not simultaneously tested. This may be relevant since other 
BC metabolites may have a bioactive antagonistic or agonistic effect. 
Another method is the use of reporter assays. A reporter gene assay contains recombi-
nant DNA containing a responsive element in combination with a reporter gene, such as 
luciferase. The reporter gene expression is easily detectable and quantifies the potency 
of the “test” substance [91]. Such assays have been developed for retinoic acid isomers 
and their metabolite potency. In these assays cells were cotransfected with a reporter 
gene containing the RARE and with vectors expressing RARα, RARβ or RARγ [92]. Plas-
ma or extractions of tissues can be tested on their ability to induce or inhibit RAR re-
sponsive transcription. Disadvantages of these assays include difficulties with the solu-
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bility or cellular uptake of the compounds of interest, or the components may be me-
tabolized, resulting in a bias in the tested potency. 
Another possibility is the (semi-) quantification of a biomarker. Biomarkers are any bio-
logical changes induced by alterations in BC or RA concentrations. In this case, a bio-
marker could be a gene which has a changed expression dependent on the concentra-
tion of BC or retinoic acid. A functional biomarker has often a high fold change in com-
bination with a low p-value. As we demonstrated in Chapter 6, BC supplementation to 
male Bcmo1-/- mice resulted in a very significant down regulation of Fzd6 and Cthrc1, in 
combination with a high absolute fold change. These genes could thus be potential 
biomarkers for RA or BC status. A regulation of Fzd6 and Cthrc1 was only significantly 
observed in male Bcmo1-/- mice and not in Bcmo1+/+ mice or female mice. In Chapter 9, 
we observed that Fzd6 was down regulated in lung tissue, liver tissue and in iWAT, 
while Cthrc1 was only significantly down regulated in lung tissue. Although an effect of 
BC would be most logical, we think that retinoic acid levels in Bcmo1-/- mice were less 
well controlled compared to Bcmo1+/+ mice after BC supplementation, which probably 
corresponds with the human situation where BC supplementation results in increased 
RA plasma levels [45]. As can be seen in Fig. 10, Fzd6 expression was also altered in 
female Bcmo1-/- mice, although just not significantly. Of course these data have to be 
interpreted very carefully, since this figure shows again opposite results in both gen-
ders, and thus this might be an effect of changes in hormone production. Further re-
search would be needed to evaluate the exact role and response of Fzd6 in BC biology. 
to see whether it can be developed into a marker for RA or BC status. 
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Figure 10: Fzd6 gene expression in mice fed the control diet (circles) or that were supplemented with 
BC (squares) as compared to control diet fed Bcmo1+/+ mice. 
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Do mechanisms of BC action in human lung tissue correspond to mechanisms 
investigated in lung tissue of animal models? 
The main difficulty when performing BC research in humans is the target tissue. It is 
virtually impossible to obtain lung tissue from volunteers since this is too invasive. 
When one is primarily interested in the immune response specifically in the lung, bron-
chioalveolar lavages can be obtained, although this is also considered as an invasive 
technique. When being interested in altered molecular mechanisms of BC action in the 
lung, the use of surrogate tissue is probably an unavoidable fact. The concept of a sur-
rogate tissue is that the questions addressed for a ‘‘target’’ tissue is determined by ana-
lyzing an accessible or ‘‘surrogate’’ tissue [93]. An often used easily accessible “surro-
gate tissue” are the human peripheral blood mononuclear cells (PBMC). Although the 
use of for example PBMC’s has been proven to be successful in profiling nutritional 
changes [94] and as a diagnostic marker for certain diseases [95,96], and for other me-
chanistic research [97], we did not isolate PBMCs for microarray analysis. Nevertheless, 
to get more insights in the tissue specificity of BC induced effects we compared the gene 
expression changes induced by BC in lung tissue with changes induced in liver and 
inguinal white adipose tissue. Interestingly, white adipose tissue can be used as an ac-
cessible tissue in human research [98,99]. As we showed in Chapter 8, only a minor 
number of genes (~1%) were similarly changed in all three tissues. However, on a path-
way level as described in Chapter 9, all of the observed altered pathways by BC in lung 
tissue were also observed in white adipose tissue and almost all effects were also ob-
served in liver tissue. This indicates that the use of surrogate tissue to investigate al-
tered mechanisms on a transcriptional level after BC supplementation may be possible. 
Nevertheless, the research has to be conducted in preferably at least two surrogate tis-
sues, to dissect surrogate tissue specific effects from the more systemic effects and has 
to be validated in, for example, animal models. Moreover, effects have to be carefully 
interpreted and validated. 
Are polymorphisms important in BC metabolism altering relative risks for lung 
cancer incidence?  
As stated in Chapter 1, individuals have been classified as “low responders” and as 
“low converters”, resulting in high inter-individual variations in BC or BC metabolite 
concentrations. polymorphisms in several genes have been demonstrated to be related 
to these phenotypes [100]. When material of the CARET or ATBC studies would be 
available, epidemiological analysis of lung cancer incidence in relation to the absence or 
presence of polymorphisms in the Bcmo1 gene would be relevant to study and might 
give answers to the questions regarding inter-individual differences in effects of BC. 
Does smoking/inflammation in combination with BC supplementation result in 
increased genotoxicity and are there differences in BC metabolism compared to 
BC supplementation to non-smokers? 
We showed in Chapter 3, that the detrimental effects of BC might be observed in smok-
ers and asbestos exposed subjects due to an increase in inflammation induced genotox-
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icity. We also showed in Chapter 2 that the effect in vivo might be different from the 
effect in vitro, and therefore it would be of importance to test whether BC increases neu-
trophil induced genotoxicity in vivo. To test this, lungs of animals can be exposed to 
lipopolysacchariden (LPS), which is a potent endotoxin recruiting circulating PMN to the 
lungs [101]. The effect of BC on for example 8-oxo-dG and M1dG can be tested. In this 
case ferrets might be an appropriate animal model, since BC metabolism is similar to 
the human situation, lung is physiologically comparable with respect to inflammation 
and, as we showed in Chapter 2, genotoxicity markers are measurable in ferrets. 
Altogether, we identified many possible processes that are affected by BC. There is also 
still much research necessary to complete gaps in the knowledge of BC action, and also 
many new questions have risen, such as: Does BC or RA change hormone synthesis 
and is Fzd6 involved in carcinogenic processes? Altogether this thesis contributes to 
our understanding of the mechanisms of action of BC knowledge and is an important 
lead for future BC research.  
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Samenvatting 
Proefschrift:  Moleculaire Werkingsmechanimsen van Bètacaroteen in 
de Long 
In het verleden is gebleken dat hoge inname van bètacaroteen (BC) het risico op het kri-
jgen van longkanker in rokers en asbest blootgestelde mensen kan verhogen. Zowel ro-
ken als asbestblootstelling zijn geassocieerd met een ontsteking in de long, en een lang-
durige ontsteking lijkt een belangrijke rol te spelen in het ontstaan en uitgroeien van 
longkanker. Een chronische ontsteking in de longen wordt gekarakteriseerd door een 
toename van een aantal witte bloedcellen (onder andere neutrofielen), welke reactieve 
zuurstof radicalen kunnen vormen die de cel beschadigen. Omdat wetenschappelijke 
studies laten zien dat BC zowel zuurstofschade kan verminderen (antioxidant) als ver-
ergeren (pro-oxidant) [1,2], hadden wij ons in het eerste gedeelte van dit proefschrift als 
doel gesteld om te onderzoeken onder welke omstandigheden BC als een antioxidant of 
een pro-oxidant fungeerd. Vervolgens onderzochten wij het effect van BC op de door 
radicalen geïnduceerde DNA schade. 
In Hoofdstuk 2 laten we zien dat de aard van het weg te vangen radicaal bepaald of BC 
een pro- of een antioxidant is; we zagen een beschermende werking van BC tegen kool-
stof gecentreerde radicalen, terwijl BC de hydroxyl radicaal geïnduceerde schade in cel-
len verhoogde. In lijn met deze bevindingen zorgde BC in fretten voor een verlaging van 
DNA schade veroorzaakt door het lipideperoxidatie product malondialdehyde (MDA), 
ook bekend als M1dG. De oxidatieve DNA laesie 8-oxo-dG, welke direct resulteert uit 
DNA oxidatie, was echter onveranderd in fretten na toevoeging van BC aan het dieet, 
waarschijnlijk omdat BC gelijktijdig de DNA herstel capaciteit verhoogde.  
Vervolgens testten we het effect van BC op neutrofiel geïnduceerde DNA schade. Geacti-
veerde neutrofielen genereren grote hoeveelheden reactieve zuurstof radicalen (reactive 
oxygen species; ROS) [3-6], welke oxidatieve DNA schade kunnen veroorzaken [7]. Bo-
vendien verlagen geactiveerde neutrofielen de cellulaire DNA herstel capaciteit [8]. In 
Hoofdstuk 3 wordt beschreven dat de BC metabolieten; vitamine A zuur (retinoic acid) 
en retinal, neutrofiel geïnduceerd oxidatieve DNA laesies verhoogden. Dit was het resul-
taat van een verlaging van de activiteit van MPO, een enzym betrokken bij de omzetting 
van neutrofiel gegenereerd waterstofperoxide, in combinatie met een versterkte omzet-
ting van waterstof peroxide resulterend in de toename van hydroxyl radicalen, door BC. 
Dit mechanisme leidde uiteindelijk tot een toename van de oxidatieve DNA schade in 
neutrofiel blootgestelde long epitheel cellen door retinoic acid en retinal. Dit wekt de 
suggestie dat negatieve effecten ten gevolge van BC inname kunnen worden verwacht 
tijdens een chronische ontsteking. 
BC of een van zijn metabolieten kan dus de genotoxiciteit van rook of asbest verande-
ren. Behalve dit effect zou BC mogelijk ook de mate waarin een gen wordt afgeschreven 
(genexpressie) wat belangrijk is voor de regulatie van een cel, kunnen veranderen. Hier-
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door kan de vatbaarheid voor rook of asbest geïnduceerde carcinogenese verder worden 
beïnvloed. Genexpressie veranderingen die geïnduceerd worden door BC inname in de 
mens zijn moeilijk te bepalen omdat aan mensen op ethische gronden geen hoge dosis 
BC meer kan worden gegeven door de resultaten van interventie studies in rokers en 
asbest blootgestelde mensen. Bovendien is long weefsel nauwelijks toegankelijk in men-
sen. De vaak gebruikte in vivo modellen, zoals ratten en muizen, verschillen echter te 
sterk in hun BC metabolisme van de mens; knaagdieren zetten BC bijna geheel om, 
terwijl de mens BC slechts deels metaboliseerd. Als gevolg hiervan resulteert BC in het 
dieet bij knaagdieren in de accumulatie van BC metabolieten, terwijl dit bij mensen re-
sulteert in de accumulatie van intact BC [9]. Hoewel andere diermodellen zoals de fret, 
de woestijnrat en kalveren, meer gelijkenis vertonen met het humane BC metabolisme 
en ook vaak gebruikt zijn voor onderzoek naar de effecten van BC, hebben deze model-
len grote nadelen. Voor wat betreft de fret of de woestijnrat als model voor de mens, is 
er weinig genetische kennis en zijn er nauwelijks commercieel verkrijgbare gereed-
schappen voor moleculair onderzoek. Gebruik van deze modellen voor BC onderzoek 
zou resulteren in pionierend onderzoek dat voornamelijk gericht is op het ontwikkelen 
van methoden, in plaats van onderzoek dat gericht is op het oplossen van mechanisti-
sche vragen. Er is meer kennis over kalveren, maar dit onderzoek is doorgaans duur en 
er is speciale huisvesting nodig. In ons onderzoek hebben we daarom gebruik gemaakt 
van een “gehumaniseerd” muizen model, welke beschreven wordt in het tweede gedeelte 
van dit proefschrift. In dit muizen model is geen functioneel beta-carotene 15,15’-
monooxygenase 1 (Bcmo1), omdat dit gen uitgeschakeld is (een zogenaamd knock-out 
model) [10]. Als gevolg hiervan kunnen deze muizen geen BC metaboliseren en zijn ze 
dus evenals mensen in staat om intact BC te accumuleren. In het tweede gedeelte van 
dit proefschrift hebben we door BC geïnduceerde veranderingen in gen expressie onder-
zocht in dit “gehumaniseerde” muizen model. Met dit onderzoek kunnen we meer in-
zicht in de functionele effecten van BC in de long krijgen. In Hoofdstuk 4 bediscussië-
ren we eerst de “in house” kennis op het gebied van functionele genomica in voeding 
interventie studies.  
Voor de bepaling van gen expressie veranderingen in vivo veroorzaakt door BC hebben 
we een muizen experiment uitgevoerd waarbij mannetjes en vrouwtjes wildtype (Bc-
mo1+/+) en Bcmo1 knock-out muizen (Bcmo1-/-) een dieet kregen dat 1500 IU vitamine A 
al dan niet met 150 mg/kg BC. 
In Hoofdstuk 5 beschrijven we het effect van BC op genexpressie veranderingen in long 
weefsel van vrouwelijke Bcmo1-/- muizen. In eerste instantie vonden we een statistisch 
betrouwbare (significante) afname in de expressie van genen betrokken bij ontstekings-
reacties in Bcmo1-/- muizen door BC. Echter, na vergelijking van deze genexpressie met 
de genexpressie in Bcmo1+/+ muizen, bleek dat de afname in de ontstekingsresponse 
eigenlijk een inductie van de ontstekingsresponse in de longen van controle Bcmo1-/- 
muizen. Deze inductie verdween wanneer er BC in het dieet aanwezig was. Histologie 
van de longen bevestigde de genexpressie resultaten, waarbij alleen ontstekingshaarden 
werden waargenomen bij controle Bcmo1-/- muizen. We konden deze bevindingen verkla-
ren door aan te nemen dat vrouwelijke Bcmo1-/- muizen een grotere vitamine A behoefte 
hebben, mede doordat enzymen betrokken bij het BC metabolisme in expressie waren 
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veranderd. Dit resulteerde in een genexpressie die veranderd was in de richting van vi-
tamine A opslag in plaats van de aanmaak van de bioactieve metaboliet retinoic acid. 
Dit is in overeenstemming met de wetenschappelijke literatuur, waarin het bekend is 
dat een deficiëntie in retinoic acid resulteert in ontstekingen.  
In Hoofdstuk 6 hebben we ons gericht op BC geïnduceerde genexpressie veranderingen 
in long weefsel van mannelijke Bcmo1-/- muizen. De toename van de ontstekingsrespons 
in longweefsel van controle Bcmo1-/- muizen bleek specifiek voor vrouwelijke Bcmo1-/- 
muizen en werd niet waargenomen in mannelijke muizen. Echter, BC suppletie aan 
mannelijke Bcmo1-/- muizen resulteerde in een sterk lagere expressie van frizzled homo-
log 6 (Fzd6) (min 2.6 keer) en collagen triple helix repeat containing 1 (Cthrc1) (min 3 
keer). Tegelijk hadden verschillende ‘olfactory’ receptoren (geurreceptoren) en protocad-
herines een hogere genexpressie. Wij hypothetiseren dat deze BC effecten specifiek 
plaats vinden in cellen die betrokken zijn bij de detectie van veranderingen in de lucht 
samenstelling in de long. ‘Pulmonary endocrine cells’ (PNECs) zijn specifiek betrokken 
bij de detectie van luchtsamenstelling en het is dus goed mogelijk dat dit specifieke cel-
type door BC beïnvloed wordt. Ondanks dat slechts 1 op de 2500 long cellen een PNEC 
cel is [11], ontstaat 20% van alle long kanker types uit PNEC en verhoogd in het bijzon-
der roken long kanker die is ontstaan uit PNEC cellen [12]. Het is belangrijk om deze 
bevindingen verder te onderzoeken en specifiek de rol van Fzd6 en Cthrc1 in PNECs en 
in relatie tot longkanker. 
BC leidde in zowel mannelijke als vrouwelijke rokers en asbest blootgestelde mensen in 
de CARET studie tot een verhoging van het longkanker risico. Daarom onderzochten we 
de gezamenlijke processen die veranderd waren in long weefsel van zowel mannelijke als 
vrouwelijke Bcmo1-/- muizen door BC in Hoofdstuk 7. De genen die zowel in vrouwelijke 
als mannelijke muizen door BC veranderd tot expressie kwamen waren tegengesteld 
veranderd in Bcmo1-/- muizen (significante toename in het ene geslacht ging gepaard 
met een afname in het andere en vice versa). Dit suggereert een rol voor BC in de regu-
latie van geslachtshormonen. De tegengestelde genexpressie veranderingen in de long 
werden vergezeld door een significante regulatie van veel enzymen betrokken bij de ste-
roïdenproductie en conversie maar alleen in de longen van mannelijke Bcmo1-/- muizen. 
Bovendien bleken testosteron niveaus zeer variabel te zijn in Bcmo1-/- muizen die BC in 
het dieet hadden, maar niet in de controle Bcmo1-/- muizen of de Bcmo1+/+ muizen. Wij 
hypothetiseren dan ook dat BC in staat is om hormoon productie of conversie te veran-
deren.  
Om een goede risico-baten analyse van BC te maken is het belangrijk om te weten of 
effecten van BC specifiek zijn voor de long. Daarom hebben we BC geïnduceerde genex-
pressie veranderingen in long weefsel vergeleken met effecten in andere organen die van 
belang zijn in de BC biologie. We vergeleken effecten in de long met effecten in wit vet-
weefsel dat belangrijk is voor de BC opslag [13], en met effecten in de lever welke be-
langrijk is voor zowel het BC metabolisme als de BC opslag [14]. 
In Hoofdstuk 8 laten we zien dat slecht een paar genen (~1%) die gereguleerd zijn door 
BC in de long, ook werden gereguleerd in lever en in het zogenaamde ‘inguinal’ wit vet-
weefsel. Hieruit blijkt dat effecten van BC op de expressie van genen zeer weefsel speci-
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fiek was. Bovendien was de hoeveelheid genen die van expressie veranderd waren door 
de BC interventie veel kleiner dan na knock-out van Bcmo1 of verschillen in geslacht 
(man versus vrouw). Ondanks dat we in Hoofdstuk 8 beschrijven dat slechts 1% van de 
genen die gereguleerd waren door BC in long weefsel ook gereguleerd waren in lever en 
vet weefsel, beschrijven we in Hoofdstuk 9 dat de processen die door BC gereguleerd 
waren in longweefsel van vrouwelijke Bcmo1-/- muizen zoals beschreven in Hoofdstuk 5 
of in mannelijke Bcmo1-/- muizen zoals beschreven in Hoofdstuk 6 of de tegengestelde 
verandering in gen expressie in mannelijke en vrouwelijke Bcmo1-/- muizen zoals be-
schreven in Hoofdstuk 7, niet specifiek voor longweefsel waren wanneer we de analyse 
op proces niveau uitvoerden. 
Samenvattend beschrijven we in dit proefschrift dat BC 1) ontstekingsgeïnduceerde ge-
notoxiciteit en 2) genexpressie in de long kan veranderen, waarbij enkele processen be-
invloedt worden die betrokken kunnen zijn bij long carcinogenese (Fig. 1). 
  233  
 
 
Figuur 1: Samenvatting van de belangrijkste bevindingen van de werking van BC in de long zoals be-
schreven in dit proefschrift, met de hoofdstukken die deze bevindingen beschrijven dik gedrukt. 
Pro-oxidant  OH• ↑ 
Antioxidant  C• ↓ 
(Hoofdstuk 2/3) 
 
M1dG ↓ (Hoofdstuk 2) 
8-oxo-dG = (Hoofdstuk 2) 
Neutrofiel geinduceeerde 8-oxo-dG ↑ (Hoofdstuk 3) 
Ontsteking: 
Gereguleerd door BC in ♀  
↑ controle Bcmo1-/-  
↓ door BC in Bcmo1-/- (Hoofdstuk 5) 
DNA herstel ↑ (Hoofdstuk 2) 
Cel deling 
PNEC cel deling ↑ in ♂ Bcmo1-/- 
(hypothese) (Hoofdstuk 6) 
Mechanismen die genotoxiciteit induceren Bescherming tegen mutaties 
Ontstaan van mutaties 
BC beïnvloed geslachtshormonen in Bcmo1-/- muizen (Hoofdstuk 7) 
 
Zijn de effecten van BC long specific? 
 
Effect van BC << effect van geslacht of Bcmo1 aanwezigheid (Hoofdstuk 8) 
Hoge mate van interactie met weefsel, geslacht en aanwezigheid (Hoofdstuk 8)  
Genen gereguleerd ~ 1% overlap met vet en lever (Hoofdstuk 8) 
Effecten op process niveau zijn niet long specifiek (Hoofdstuk 9) 
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